Search | IOVS | ARVO Journals

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Turner D Wibbelsman; Daniel B Calem; Anthony Obeid; Phoebe L Mellen; Michelle A. Konkoly; Michael R. Velez; Kareem Sioufi; Durga S Borkar; Ravi Pandit; Michael A. Klufas; Jason Hsu; Carl Regillo; Allen C Ho; Omesh P Gupta; Marc J. Spirn

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4057. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Outcomes of Eyes Lost to Follow-Up with Neovascular Age Related Macular Degeneration Receiving Intravitreal Anti-VEGF

Rebecca Russ Soares; Phoebe L Mellen; Hannah Garrigan; Anthony Obeid; Turner D Wibbelsman; Durga S Borkar; Allen C Ho; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1197. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

CEP290 -associated LCA due to a photoreceptor cilium defect treated with an intravitreal antisense oligonucleotide results in improved vision

Artur V Cideciyan; Samuel G Jacobson; Arlene V Drack; Allen C Ho; Alexandra Garafalo; Alejandro J Roman; Mike Schwartz; Patricia Biasutto; Wilma de Wit; Michael E Cheetham; Peter S Adamson; David Rodman; Julie De Zaeytijd; Caroline Van Cauwenbergh; Bart P Leroy; Stephen R Russell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1834. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Endophthalmitis following cataract surgery: visual outcomes and culture results

Hannah J Levin; Philip Storey; Maitri Pancholy; Samir N Patel; Turner D Wibbelsman; Anthony Obeid; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2033. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Etiology, treatment and visual outcomes of patients with choroidal neovascularization under the age of 50

David Xu; Anthony Obeid; Hannah J Levin; Douglas Matsunaga; Kalla A Gervasio; Thomas L Jenkins; Ravi R Pandit; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5047. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Treatment and Management of Neovascular AMD: Impact on Patients

Vincent W Li; Isaac R. Gabriel; Madeleine M Li; Andrew N Antoszyk; Carl W Baker; Pravin U Dugel; Roger A. Goldberg; Jeffrey S. Heier; Allen C Ho; John S Pollack; Charles Clifton Wykoff; Demetrios Vavvas; William W Li

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):136. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Sociodemographic disparities in presenting visual acuity of neovascular age related macular degeneration patients

Meera Diana Sivalingam; Kalla A Gervasio; Connie M Wu; Douglas Matsunaga; Joshua Uhr; Anthony Obeid; Turner D Wibbelsman; Hannah Levine; Ravi R Pandit; Thomas Jenkins; David Xu; Jason Hsu; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):69. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Factors predicting distribution and practice patterns of retina providers across the United States (US)

Ravi Pandit; Turner D Wibbelsman; Thomas Jenkins; David Xu; Anthony Obeid; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3961. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Jason Hsu; Anthony Obeid; Phoebe L Mellen; Turner D Wibbelsman; Michelle A. Konkoly; Michael R. Velez; Daniel B. Calem; Kareem Sioufi; Daniel Su; Philip Storey; Michael A. Klufas; Marc J. Spirn; Carl Regillo; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):80. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

A Comparison of Optical Coherence Tomography Angiography to Fluorescein Angiography for the Imaging of Type 1 Neovascularization

Maiko Inoue; Jesse J Jung; Chandra Bala; Talisa E de Carlo; Abtin Shahlaee; Michael A Klufas; Jay S Duker; Allen C Ho; Maddalena QUARANTA EL-MAFTOUHI; David Sarraf; K Bailey Freund

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Endoillumination Levels and Display Luminous Emittance During Three-Dimensional Heads-Up Vitreoretinal Surgery

Sarah Thornton; Murtaza K Adam; Allen C Ho; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4467. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Disease Burden Associated with Geographic Atrophy Secondary to Age-related Macular Degeneration

Susan C Orr; Renee Pierson; Jennifer Bogert; Tom Chang; Terri Malone; Ross Crosby; Susan Mathias; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):21. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Consistency of visual acuity response to anti-VEGF therapy in diabetic macular edema patients: An analysis of DRCRnet Protocol I data

Scott M Whitcup; Joanna Campbell; Nancy Holekamp; Szilard Kiss; Anat Loewenstein; Albert J Augustin; Allen C Ho; Victor Gonzalez; Vanessa Shih; Amelia Orejudos; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Prospective, Multicenter Investigation of Aflibercept Treat and Extend Therapy for Neovascular Age-related Macular Degeneration (ATLAS Study): One and Two Year Results

Francis Char DeCroos; David Carleton Reed; Murtaza K Adam; David A Salz; Omesh Gupta; Allen C Ho; Carl D Regillo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

Articles July 2016

A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization

PDF

Maiko Inoue; Jesse J. Jung; Chandrakumar Balaratnasingam; Kunal K. Dansingani; Elona Dhrami-Gavazi; Mihoko Suzuki; Talisa E. de Carlo; Abtin Shahlaee; Michael A. Klufas; Adil El Maftouhi; Jay S. Duker; Allen C. Ho; Maddalena Quaranta-El Maftouhi; David Sarraf; K. Bailey Freund; for the COFT-1 Study Group
TAGS: angiogram, face, fluorescein angiography, neovascularization, pathologic, diagnostic imaging, eye, optical coherence tomography
Invest. Ophthalmol. Vis. Sci.. 2016; 57(9):OCT314-OCT323. doi: https://doi.org/10.1167/iovs.15-18900

ARVO Annual Meeting Abstract June 2015

Five-year data from the Argus II Retinal Prosthesis System Clinical Tria

Robert Jay Greenberg; Mark S Humayun; Lyndon da Cruz; Gislin Dagnelie; Paulo E Stanga; Allen C Ho; David G Birch; Jacque L Duncan; José Sahel; Argus II Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):754. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Management of symptomatic floaters: Current attitudes, beliefs, and practices among vitreoretinal surgeon

Michael Nathan Cohen; Ehsan Rahimy; Allen C Ho; Sunir J Garg

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5100. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Spectrum of Retinal Vascular Diseases Associated with Paracentral Middle Maculopathy

Xuejing Chen; Ehsan Rahimy; Netan Choudhry; Amani A Fawzi; Allen C Ho; Jean-Pierre Hubschman; Marion Ronit Munk; Robert Sergott; Eduardo Cunha Souza; David Sarraf

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5926. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Prospective Evaluation of Intravitreal Bevacizumab on Outcomes of Proliferative Vitreoretinopathy (PVR)-related Retinal Detachment Surgery

Wen-Shi Shieh; Mohammed Ali Khan; Jason Hsu; Allen C Ho; Sunir J Garg; Richard S Kaiser; Carl H Park; Joseph Maguire; Allen Chiang

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):162. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2014

An Update on the Argus II Epiretinal Implant

Mark S Humayun; Lyndon Da Cruz; Gislin Dagnelie; Paulo E Stanga; Allen C Ho; Robert Jay Greenberg; David G Birch; Jacque L Duncan; Jose-Alain Sahel; Argus II Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5968. doi: https://doi.org/

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Outcomes of Eyes Lost to Follow-Up with Neovascular Age Related Macular Degeneration Receiving Intravitreal Anti-VEGF

CEP290 -associated LCA due to a photoreceptor cilium defect treated with an intravitreal antisense oligonucleotide results in improved vision

Endophthalmitis following cataract surgery: visual outcomes and culture results

Etiology, treatment and visual outcomes of patients with choroidal neovascularization under the age of 50

Treatment and Management of Neovascular AMD: Impact on Patients

Sociodemographic disparities in presenting visual acuity of neovascular age related macular degeneration patients

Factors predicting distribution and practice patterns of retina providers across the United States (US)

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

A Comparison of Optical Coherence Tomography Angiography to Fluorescein Angiography for the Imaging of Type 1 Neovascularization

Endoillumination Levels and Display Luminous Emittance During Three-Dimensional Heads-Up Vitreoretinal Surgery

Disease Burden Associated with Geographic Atrophy Secondary to Age-related Macular Degeneration

Consistency of visual acuity response to anti-VEGF therapy in diabetic macular edema patients: An analysis of DRCRnet Protocol I data

Prospective, Multicenter Investigation of Aflibercept Treat and Extend Therapy for Neovascular Age-related Macular Degeneration (ATLAS Study): One and Two Year Results

A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization

Five-year data from the Argus II Retinal Prosthesis System Clinical Tria

Management of symptomatic floaters: Current attitudes, beliefs, and practices among vitreoretinal surgeon

Spectrum of Retinal Vascular Diseases Associated with Paracentral Middle Maculopathy

Prospective Evaluation of Intravitreal Bevacizumab on Outcomes of Proliferative Vitreoretinopathy (PVR)-related Retinal Detachment Surgery

An Update on the Argus II Epiretinal Implant

To View More...

You must be signed into an individual account to use this feature.